|
|
||||||||||
|
J Am Coll Cardiol, 1996; 28:565-572 © 1996 by the American College of Cardiology Foundation |
Department of Medicine, University of California Los Angeles School of Medicine 90095-1679, USA.
OBJECTIVES: This study sought to measure myocardial blood flow at rest and during dobutamine infusion and to correlate flow with cardiac work and severity of coronary artery disease. BACKGROUND: Dobutamine is used with cardiac imaging to induce possible ischemia in patients with known or suspected coronary artery disease. Positron emission tomography permits noninvasive quantitation of myocardial blood flow. METHODS: Fifteen patients with quantitative coronary arteriography were studied at rest and during dobutamine infusion using nitrogen-13 ammonia flow imaging with positron emission tomography. Myocardial blood flow was determined in regions corresponding to the three major coronary arteries for myocardium with and without dobutamine flow defects and with and without a > 50% diameter stenosis. RESULTS: Eight patients had at least one dobutamine flow defect; four of whom had a previous myocardial infarction. One patient with > 50% diameter stenosis had no flow defects, and one with < 50% diameter stenosis (48%) had one defect. Dobutamine significantly increased myocardial blood flow in regions with and without a dobutamine flow defect or > 50% diameter stenosis, with a greater increase when a defect or > 50% diameter stenosis was not present. Rest and dobutamine flows in regions without > 50% diameter stenosis were 0.93 +/- 0.20 (mean +/- SD) and 2.16 +/- 0.52 ml/min per g (p < 0.01), respectively. The corresponding flows in regions without a defect were 0.94 +/- 0.21 and 2.17 +/- 0.53 ml/min per g (p < 0.01), respectively. This 2, 4-fold increase in flow was significantly correlated (p < 0.001) with a 2.2-fold increase in rate-pressure product induced by dobutamine. The rest and dobutamine flows for regions subtended by a vessel with > 50% diameter stenosis were 0.70 +/- 0.33 and 1.20 +/- 0.54 ml/min per g (p < 0.05), respectively, whereas the corresponding values for regions with a dobutamine flow defect were 0.69 +/- 0.33 ml/min per g at rest and 1.23 +/- 0.54 ml/min per g during dobutamine (p < 0.05). Dobutamine increased flow inversely proportional to percent diameter stenosis. The rest flow for regions with a dobutamine flow defect were not significantly different from that in regions without defects. CONCLUSIONS: Dobutamine resulted in a significant increase in myocardial blood flow that correlated significantly with both increased cardiac work and degree of stenosis.
This article has been cited by other articles:
![]() |
T.-H. Park, N. Tayan, K. Takeda, H.-K. Jeon, M. A. Quinones, and W. A. Zoghbi Supine Bicycle Echocardiography: Improved Diagnostic Accuracy and Physiologic Assessment of Coronary Artery Disease With the Incorporation of Intermediate Stages of Exercise J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1857 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Attili and P. N. Cascade CT and MRI of Coronary Artery Disease:Evidence-Based Review. Am. J. Roentgenol., December 1, 2006; 187(6 Suppl): S483 - S499. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Jagathesan, E Barnes, S D Rosen, R Foale, and P G Camici Dobutamine-induced hyperaemia inversely correlates with coronary artery stenosis severity and highlights dissociation between myocardial blood flow and oxygen consumption Heart, September 1, 2006; 92(9): 1230 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Senior, M Monaghan, H Becher, J Mayet, and P Nihoyannopoulos Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography Heart, April 1, 2005; 91(4): 427 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jagathesan, P. A. Kaufmann, S. D. Rosen, O. E. Rimoldi, F. Turkeimer, R. Foale, and P. G. Camici Assessment of the Long-Term Reproducibility of Baseline and Dobutamine-Induced Myocardial Blood Flow in Patients with Stable Coronary Artery Disease J. Nucl. Med., February 1, 2005; 46(2): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yip, B. Khandheria, M. Belohlavek, C. Pislaru, J. Seward, K. Bailey, A. J. Tajik, P. Pellikka, and T. Abraham Strain echocardiography tracks dobutamine-induced decrease in regional myocardial perfusion in nonocclusive coronary stenosis J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1664 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Wyss, P. Koepfli, K. Mikolajczyk, C. Burger, G. K. von Schulthess, and P. A. Kaufmann Bicycle Exercise Stress in PET for Assessment of Coronary Flow Reserve: Repeatability and Comparison with Adenosine Stress J. Nucl. Med., February 1, 2003; 44(2): 146 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Scognamiglio, A. Avogaro, S. Vigili de Kreutzenberg, C. Negut, M. Palisi, E. Bagolin, and A. Tiengo Effects of Treatment With Sulfonylurea Drugs or Insulin on Ischemia-Induced Myocardial Dysfunction in Type 2 Diabetes Diabetes, March 1, 2002; 51(3): 808 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takeuchi, C. Miyazaki, H. Yoshitani, S. Otani, K. Sakamoto, and J. Yoshikawa Assessment of coronary flow velocity with transthoracic Doppler echocardiography during dobutamine stress echocardiography J. Am. Coll. Cardiol., July 1, 2001; 38(1): 117 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tadamura, H. Iida, K. Matsumoto, M. Mamede, S. Kubo, H. Toyoda, T. Shiozaki, T. Mukai, Y. Magata, and J. Konishi Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men J. Am. Coll. Cardiol., January 1, 2001; 37(1): 130 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takehana, M. Ruiz, F. D. Petruzella, D. D. Watson, G. A. Beller, and D. K. Glover Response to incremental doses of dobutamine early after reperfusion is predictive of the degree of myocardial salvage in dogs with experimental acute myocardial infarction J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1960 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Senior and A Lahiri Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging Heart, December 1, 1999; 82(6): 668 - 673. [Abstract] [Full Text] |
||||
![]() |
C. A. Schneider, E. Voth, D. Moka, F. M. Baer, J. Melin, A. Bol, R. Wagner, H. Schicha, E. Erdmann, and U. Sechtem Improvement of myocardial blood flow to ischemic regions by angiotensin- converting enzyme inhibition with quinaprilat IV: A study using [15O] water dobutamine stress positron emission tomography J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1005 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schoder, R. Campisi, T. Ohtake, C. K. Hoh, D. H. Moon, J. Czernin, and H. R. Schelbert Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1328 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Skopicki, S. A. Abraham, M. H. Picard, N. M. Alpert, A. J. Fischman, and H. Gewirtz Effects of Dobutamine at Maximally Tolerated Dose on Myocardial Blood Flow in Humans With Ischemic Heart Disease Circulation, November 18, 1997; 96(10): 3346 - 3352. [Abstract] [Full Text] |
||||
![]() |
D. A. Calnon, D. K. Glover, G. A. Beller, G. Vanzetto, W. H. Smith, D. D. Watson, and M. Ruiz Effects of Dobutamine Stress on Myocardial Blood Flow, 99mTc Sestamibi Uptake, and Systolic Wall Thickening in the Presence of Coronary Artery Stenoses : Implications for Dobutamine Stress Testing Circulation, October 7, 1997; 96(7): 2353 - 2360. [Abstract] [Full Text] |
||||
![]() |
K. T. Sun, J. Czernin, J. Krivokapich, Y.-K. Lau, M. Bottcher, G. Maurer, M. E. Phelps, and H. R. Schelbert Effects of Dobutamine Stimulation on Myocardial Blood Flow, Glucose Metabolism, and Wall Motion in Normal and Dysfunctional Myocardium Circulation, December 15, 1996; 94(12): 3146 - 3154. [Abstract] [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |